PPAR-α ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 5 56-5, 2004, Pages

  Li, Shenyang ^a   Bhatt, Renu ^a   Megyesi, Judit ^a   Gokden, Neriman ^a   Shah, Sudhir V ^a   Portilla, Didier ^a,b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Fatty acid oxidation; Peroxisome proliferator activated receptor

Indexed keywords

CISPLATIN; ENDONUCLEASE; ENDONUCLEASE G; LIGAND; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; INTRACELLULAR TRANSPORT; KIDNEY FUNCTION; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

EID: 6344285851     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00206.2004     Document Type: Article

References (40)

1. Basnakian AG, Kaushal GP, and Shah SV. Apoptotic pathways of oxidative damage to renal tubular epithelial cells. Antiox Redox Signal 4: 915-924, 2002.
2. Basnakian AG, Ueda N, Kaushal GP, Mikhailova MV, and Shah SV. DNAse I-like endonuclease in rat kidney cortex that is activated during ischemia/repeifusion injury. J Am Soc Nephrol 13: 1000-1007, 2002.
3. Beck F, Plummer S, Senior PV, Byrne S, Green S, and Brammar WJ. The ontogeny of peroxisome proliferator-activated receptor gene expression in the mouse and rat. Proc R Soc Land B Biol Sci 247: 83-87, 1992.
4. Boitier E, Gautier JC, and Roberts R. Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease. Comp Hepatol 2: 3, 2003.
5. Du C, Fang M, Li Y, Li L, and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
6. Escriva H, Safi R, Hanni C, Langlois MC, Saumitou-Laprade P, Stehelin D, Capron A, Pierce R, and Laudet V. Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 94: 6803-6808, 1997.
7. Gross A, McDonnell JM, and Korsmeyer SJ. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
8. Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandes-Alnemri T, and Alnemri ES. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 277: 432-438, 2002.
9. Kelleher SP, Robinette JB, Miller F, and Conger JD. Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. Kidney Int 31: 725-730, 1987.
10. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, and Evans RM. Differential expression and activation of a family of murine peroxisome proliferators-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994.
11. Kuwana T and Newmeyer DD. Bcl-2 family proteins, and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15: 691-699, 2003.
12. Li LY, Luo X, and Wang X. Endonuclease G is an apoptotic DNAse when released from mitochondria. Nature 412: 95-99, 2001.
13. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase 9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 2004.
14. Li S, Wu P, Yarlagadda P, Vadjunec NM, Proia AD, Harris RA, and Portilla D. PPARα ligand protects during cisplatin induced acute renal failure by preventing inhibition of renal FAO and PDC activity. Am J Physiol Renal Physiol 286: F572-F580, 2004.
15. Low RL and Gerschenson M. Endonuclease G isolation and assays. Methods Mol Biol 197: 331-349, 2002.
16. Macdonald N, Barrow K, Tonge R, Davison M, Roberts RA, and Chevalier S. PPARα-dependent alteration of GRP94 expression in mouse hepatocytes. Biochem Biophys Res Commun 277: 699-704, 2000.
17. Martinou JC and Green DR. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2: 63-67, 2001.
18. McManus JFA. Histological and histochemical uses of periodic acid. Stain Technol 23: 99-108, 1948.
19. Megyesi J, Udvarhelyi N, Safirstein RL, and Price PM. The p53-independent activation of transcription of p21 WAF1/C1P1/SDI1 after acute renal failure. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1211-F1216, 1996.
20. Portilla D. Energy metabolism and cytotoxicity. Semin Nephrol 23: 432-438, 2003.
21. Portilla D, Dai G, McClure T, Bates L, Kurten R, Megyesi J, Price P, and Li S. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney Int 62: 1208-1218, 2002.
22. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, and Proia AD. Etomoxir-induced PPARα-modulated enzymes protects during acute renal failure. Am J Physiol Renal Physiol 278: F667-F675, 2000.
23. Portilla D, Kurten R, and Kaushal GP. PPARα but not PPAR-γ ligands protect against cisplatin induced renal tubular epithelial cell injury (Abstract). J Am Soc Nephrol 13: pp138A, 2002.
24. Ramesh G and Reeves WB. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 285: F610-F618, 2003.
25. Ries F and Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 13: 368-379, 1986.
26. Roberts RA, Chevalier S, Hasmall SC, James NH, Cosulich SC, and Mcdonald N. PPARα and the regulation of cell division and apoptosis. Toxicology 182: 167-170, 2002.
27. Sheikh-Hamad D, Cacini W, Buckley AR, Isaac J, Truong LD, and Tsao C. Kishore BK cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 78: 147-155, 2003.
28. Smirnov AN. Nuclear receptors: nomenclature, ligands, mechanisms of their effects on gene expression. Biochemistry 67: 957-977, 2002.
29. Solez K, Morel-Maroger L, and Sraer JD. The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 58: 362-376, 1979.
30. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, and Deavarajan P. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63: 1714-1724, 2003.
31. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446, 1999.
32. Suzuki M, Youle RJ, and Tjandra N. Structure of Bax: coregulation of dimmer formation and intracellular localization. Cell 103: 645-654, 2000.
33. Thornberry NA and Lazebnik Y. Caspases: enemies within. Science 281: 1312-1316, 1998.
34. Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, and Iida M. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63: 72-82, 2003.
35. Van Gurp M, Festjens N, van Loo G, Saelens X, and Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304: 487-497, 2003.
36. Van Loo G, Schotte P, van Gurp M, Demol H, Hoorelbeke B, Gevaert K, Rodriguez I, Ruiz-Carrillo A, Vandekerckhove J, Declerq W, Beyaert R, and Vandenabeele P. Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 8: 1136-1142, 2001.
37. Verhagen AM, Ekertt PG, Pakusch m., Silke J, Connolly JM, Reid GE, Moritz RL, Simpson RJ, and Vaux DL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to an antagonizing IAP proteins. Cell 102: 43-53, 2000.
38. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, and Vaux DL. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454, 2002.
39. Zamzami N and Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2: 67-71, 2001.
40. Zhang J, Dong M, Li L, Fan Y, Pathre P, Dong J, Lou D, Wells JM, Olivares-Villagomez D, Van Kaer L, Wang X, and Xu M. Endonuclease G is required for early embryogenesis, and normal apoptosis in mice. Proc Natl Acad Sci USA 100: 15782-15787, 2003.